Press Releases

Date	Title	PDF Version
Oct 16, 2013	Researchers to Present New Data on Soliris® (eculizumab) as a Treatment for Patients with aHUS at ASN Annual Meeting
Oct 10, 2013	Alexion Pharmaceuticals to Report Third Quarter 2013 Results on Thursday, October 24, 2013
Sep 22, 2013	New Data Evaluating Asfotase Alfa in Infants and Young Children with Hypophosphatasia (HPP) Presented at Paediatric Endocrinology Meeting
Sep 13, 2013	Alexion's Soliris® (eculizumab) Receives Marketing Approval in Japan for All Patients with aHUS
Sep 10, 2013	Study Evaluating Eculizumab (Soliris®) in Preventing Antibody-Mediated Rejection (AMR) in Kidney Transplant Recipients Presented at the European Society for Organ Transplantation (ESOT) Annual Congress
Sep 04, 2013	Alexion to Present at Morgan Stanley Global Healthcare Conference
Jul 25, 2013	Alexion Reports Second Quarter 2013 Results
Jul 16, 2013	Alexion's Soliris® (eculizumab) Receives Positive Opinion from the Committee for Orphan Medicinal Products for Treatment of Neuromyelitis Optica (NMO)
Jul 11, 2013	Alexion Pharmaceuticals to Report Second Quarter 2013 Results on Thursday, July 25, 2013
Jun 27, 2013	Alexion's Soliris® (eculizumab) Receives Orphan Drug Designation for the Treatment of Neuromyelitis Optica (NMO)

Search